🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A study to evaluate the effect of over- the- counter (OTC) lubricating eye ...
Status
Recruiting
Location
Andover Eye Associates
Start Date
2026-06-03
Trial ID
NCT07676084
To investigate the pharmacokinetic effect of a vaginally administered antim...
Status
Completed
Location
Multiple Locations
Start Date
2015-09-15
Trial ID
NCT02545452
A single-centre Phase 1b study to assess the safety, tolerability, pharmaco...
Status
Completed
Location
Q-Pharm
Start Date
2018-04-23
Trial ID
NCT03542149
Efficacy and Safety of the Ophthalmic Solution PRO-087 versus Systane ® Ult...
Status
Completed
Location
Fernando Rodriguez Sixtos Higuera
Start Date
2016-10-13
Trial ID
NCT03223909
Treatments Being Tested
This study was to assess whether sofosbuvir in combination with ribavirin (...
Status
Completed
Location
University of Alabama Birmingham
Start Date
2012-06
Trial ID
NCT01641640
Treatments Being Tested
The primary objective of the Single Rising Dose (SRD) part (trial part 1) i...
Status
Completed
Location
Humanpharmakologisches Zentrum Biberach
Start Date
2017-01-12
Trial ID
NCT03004404
Efficacy and acceptability of two new artificial tears following two weeks ...
Status
Completed
Location
Multiple Locations
Start Date
2008-09
Trial ID
NCT00756678
Treatments Being Tested
Interleukin 29 (IL-29) is a substance that is produced in the body to help ...
Status
Unknown
Location
Multiple Locations
Start Date
2010-05
Trial ID
NCT01001754
Treatments Being Tested
This study will evaluate the efficacy and safety of NEUTRINO regimen in Chi...
Status
Completed
Location
Liver Fibrosis Diagnosis and Treatment Centre, 302 Hospital
Start Date
2015-01
Trial ID
NCT02480686
Treatments Being Tested
This study is to evaluate the overall efficacy, and safety profile of the t...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2012-03
Trial ID
NCT01500772
Treatments Being Tested